Article
Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its…
Drugs in context · 2019 · D. Bagnasco, M. Biava, N. Facciolongo, C. Galeone, F. Menzella, P. Ruggiero, A. Simonazzi
Key facts
| Title | Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors? |
|---|---|
| First author | D. Bagnasco, M. Biava, N. Facciolongo, C. Galeone, F. Menzella, P. Ruggiero, A. Simonazzi |
| Journal | Drugs in context |
| Published | Apr 15, 2019 |
| DOI | 10.7573/dic.212580 |
| PubMed ID | 31024635 |
| PMC ID | PMC6469746 |
| Devices mentioned | 212580 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1